Adia Nutrition, Inc. Liquidation Value
Cash & Equivalents
Key Metrics
Cash Liquidation Value
Liquid Liquidation Value
Operating Liquidation Value
Build your own liquidation scenario
Adjust asset discounts and liability assumptions to see how assumptions affect the numbers.
Liquidation Ladder
| Metric | Total | Per Share |
|---|---|---|
| Cash Liquidation Value | $-173,108 | $-0.00 |
| Liquid Liquidation Value | $-139,748 | $-0.00 |
| Operating Liquidation Value | $-114,723 | $-0.00 |
Key Components (as of 2025-12-31)
| Cash & Equivalents | $79,392 |
| Accounts Receivable | $33,360 |
| Inventory | $25,025 |
| Current Liabilities | $145,195 |
| Long-term Debt (?) | N/A |
| Op. Lease Liability (?) | $45,918 |
| Finance Lease (?) | $61,387 |
| Shares Outstanding | 93.6M |
Explore all 136 XBRL tags and build your own scenario → Open Calculator
Historical
| Period | Cash | AR | Inventory | AP | Curr Liab | LT Debt | Op Lease | Fin Lease |
|---|---|---|---|---|---|---|---|---|
| 2025-12-31 | $79,392 | $33,360 | $25,025 | $2,393 | $145,195 | N/A | $45,918 | $61,387 |
| 2024-12-31 | $6,323 | $0 | $206,886 | $4,876 | $79,993 | N/A | $104,089 | $88,030 |
| 2023-12-31 | $500 | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
SEC Filings
| Period | Form | Filed | Link |
|---|---|---|---|
| 2025-12-31 | 10-K | 2026-03-31 | View |
AI Insights
Adia Nutrition, Inc. (ADIA) presents a deeply negative liquidation posture at December 31, 2025. Total assets of $594,826 are dominated by non-cash, low-recovery items; total liabilities stand at $852,500, yielding GAAP book equity of negative $257,674. The MFFAIS-reported cash liquidation value of negative $173,108 and liquid liquidation value of negative $139,748 reflect the same structural problem: liabilities exceed recoverable asset values at every haircut level.
Applying standard liquidation haircuts to reported assets: Cash of $79,392 recovers at 100% ($79,392). Accounts receivable of $33,360 recovers at ~92% (~$30,691). The $72,107 receivable from Cement Factory, LLC on the Biolete inventory/trademark sale is a concentrated, unsecured obligation from a related non-consolidated startup entity that has not yet generated a profit; recovery is speculative, warranting a severe haircut or full write-off in a stress scenario. Inventory of $25,025 (biologic products) recovers at 60% (~$15,015). PP&E net of $30,695 recovers at 50-60% (~$15,000-$18,000). The operating lease ROU asset of $107,843 and finance lease ROU asset of $108,171 carry zero liquidation value under this lens. The 18% equity stake in Cement Factory, LLC (carried at cost, amount not separately XBRL-tagged in this filing but discussed in MD&A as valued at original consideration) has indeterminate but likely minimal liquidation value given the entity's unprofitability. Prepaid expenses of $23,483 recover at minimal to zero. Deposit of $10,000 may recover at face.
On the liability side, face-value obligations include: CEO line of credit principal $600,000 plus accrued interest $37,915 (total $637,915), operating lease obligations $109,868, finance lease obligations $88,171, accounts payable $2,393, deferred revenue $14,000, and accrued payroll/other current liabilities ~$2,700. Combined lease obligations of $198,039 do not extinguish on windup and must be settled or negotiated.
The dominant liability is the $600,000 unsecured, demand-callable line of credit extended by the CEO himself, bearing 6% interest with no stated maturity. This related-party structure creates a conflict-of-interest risk in any liquidation scenario, as the largest creditor controls management. At December 31, 2025, the line of credit alone exceeds total assets. The accumulated deficit of $15,973,482 reflects the deep historical loss position. The filing carries an explicit going concern qualification. No prior period filing was provided for YoY comparison.
▼ Community Notes